Bapineuzumab (APP Abeta) - Research Grade Biosimilar
Product Specifications
Background
Bapineuzumab has been investigated for the treatment of Alzheimer's Disease.
Immunogen
Humanized / APP Abeta [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Neuroscience
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Product Datasheet
https://www.prosci-inc.com/?datasheet_sku=10-270
Fragment
IgG1-nd
NCBI Organism
Homo sapiens
Other Product Names
AAB-001
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1312298-01 0.02 mg (E-Coli)
Recombinant Rhizobium meliloti Probable sugar isomerase R00627 (R00627)
Ask
View Details